Economic_NewsAstraZeneca wins shareholder approval for New York listing Rutt ontrd6 months ago01 mins Post Views: 170 Move by FTSE’s biggest company gains support of 99% of shareholders who voted in blow to London market 0 Reviews Post navigation Previous: AstraZeneca wins vote to press ahead with New York listingNext: Gold Price Forecast: XAU/USD failing to retain $4,000 amid broad US Dollar demand
Wholesale inflation jumps 6% in April on annual basis, biggest increase since 2022 Rutt ontrd3 hours ago 0
IEA warns of further price spikes as global oil inventories fall at record pace Rutt ontrd8 hours ago 0